Lars Orö

1.9k total citations
39 papers, 1.4k citations indexed

About

Lars Orö is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Physiology. According to data from OpenAlex, Lars Orö has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pharmacology and 9 papers in Physiology. Recurrent topics in Lars Orö's work include Inflammatory mediators and NSAID effects (7 papers), Pharmacology and Obesity Treatment (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Lars Orö is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Pharmacology and Obesity Treatment (6 papers) and Analytical Methods in Pharmaceuticals (5 papers). Lars Orö collaborates with scholars based in Sweden. Lars Orö's co-authors include Lars A. Carlson, Lars‐Göran Ekelund, Sune Bergström, Jan Castenfors, Anders Olsson, Hans Johnsson, Jan Östman, Lennart Levi, Sven O. Fröberg and A. Wretlind and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Lars Orö

39 papers receiving 1.1k citations

Peers

Lars Orö
Harriet M. Maling United States
F. J. Haddy United States
J A Oates United States
J. Richard Crout United States
Samuel J. Friedberg United States
Andrew M. Michelakis United States
David L. Trout United States
Michael S. Golub United States
S Sgambato Italy
McC. Goodall United States
Harriet M. Maling United States
Lars Orö
Citations per year, relative to Lars Orö Lars Orö (= 1×) peers Harriet M. Maling

Countries citing papers authored by Lars Orö

Since Specialization
Citations

This map shows the geographic impact of Lars Orö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Orö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Orö more than expected).

Fields of papers citing papers by Lars Orö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Orö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Orö. The network helps show where Lars Orö may publish in the future.

Co-authorship network of co-authors of Lars Orö

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Orö. A scholar is included among the top collaborators of Lars Orö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Orö. Lars Orö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsson, Anders & Lars Orö. (1982). Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Atherosclerosis. 42(2-3). 229–243. 20 indexed citations
2.
Orö, Lars, et al.. (1978). Serum lipoprotein concentrations in chronic uremia. American Journal of Clinical Nutrition. 31(10). 1881–1885. 14 indexed citations
3.
Rössner, Stephan, Anders Olsson, & Lars Orö. (1976). The Effects of Different Dose Regimens of Niceritrol on Serum Lipid Concentrations in Man. Acta Medica Scandinavica. 200(1-6). 269–271. 2 indexed citations
4.
Olsson, Anders, Lars Orö, & Stephan Rössner. (1974). Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate. Atherosclerosis. 19(3). 407–415. 8 indexed citations
5.
Olsson, Anders, Lars Orö, & Stephan Rössner. (1974). Clinical and metabolic effects of pentaerythritol tetranicotinate (perycit®) and a comparison with plain nicotinic acid. Atherosclerosis. 19(1). 61–73. 23 indexed citations
6.
Jönsson, Bengt, Anders Olsson, & Lars Orö. (1973). Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.. PubMed. 58(3). 152–61. 4 indexed citations
7.
Castenfors, Jan, Hans Johnsson, & Lars Orö. (1973). EFFECT OF ALPRENOLOL ON BLOOD PRESSURE AND PLASMA RENIN ACTIVITY IN HYPERTENSIVE PATIENTS. Acta Medica Scandinavica. 193(1-6). 189–195. 84 indexed citations
8.
Jönsson, Bengt, Anders Olsson, & Lars Orö. (1973). Effects of Alprenolol on Central Hemodynamics and Exercise Tolerance in Patients with Angina Pectoris. Cardiology. 58(3). 150–161. 5 indexed citations
9.
Carlson, Lars A., Lennart Levi, & Lars Orö. (1972). 5 STRESSOR‐INDUCED CHANGES IN PLASMA LIPIDS AND URINARY EXCRETION OF CATECHOLAMINES, AND THEIR MODIFICATION BY NICOTINIC ACID. Acta Medica Scandinavica. 191(S528). 91–105. 9 indexed citations
10.
Castenfors, Jan, et al.. (1970). PLASMA RENIN ACTIVITY IN PATIENTS WITH DISTURBED SYMPATHETIC VASOMOTOR CONTROL (POSTURAL HYPOTENSION)1. Acta Medica Scandinavica. 188(1-6). 385–388. 14 indexed citations
11.
Carlson, Lars A., Lars‐Göran Ekelund, & Lars Orö. (1970). CLINICAL, METABOLIC AND CARDIOVASCULAR EFFECTS OF DIFFERENT PROSTAGLANDINS IN MAN. Acta Medica Scandinavica. 188(1-6). 553–559. 17 indexed citations
12.
Carlson, Lars A., Lars‐Göran Ekelund, & Lars Orö. (1970). EFFECT OF INTRAVENOUS PROSTAGLANDIN E1ON NORADRENALINE‐STIMULATED MOBILIZATION OF PLASMA FREE FATTY ACIDS IN MAN. Acta Medica Scandinavica. 188(1-6). 379–383. 2 indexed citations
13.
Carlson, Lars A., Lars‐Göran Ekelund, & Lars Orö. (1968). CLINICAL AND METABOLIC EFFECTS OF DIFFERENT DOSES OF PROSTAGLANDIN E1 IN MAN. Acta Medica Scandinavica. 183(1-6). 423–430. 123 indexed citations
14.
Orö, Lars, et al.. (1965). Influence of Electrical Supramedullary Stimulation on the Plasma Level of Free Fatty Acids, Blood Pressure and Heart Rate in the Dog. Acta Medica Scandinavica. 178(6). 697–711. 16 indexed citations
15.
Bergström, Sune, Lars A. Carlson, Lars‐Göran Ekelund, & Lars Orö. (1965). Cardiovascular and Metabolic Response to Infusions of Prostaglandin E1 and to Simultaneous Infusions of Noradrenaline and Prostaglandin E1 in Man Prostaglandin and related factors 35. Acta Physiologica Scandinavica. 64(4). 332–339. 102 indexed citations
16.
Orö, Lars. (1964). Studies on the Acute Effect of Guanethidine on the Free Fatty Acids of Plasma in the Dog. Acta Medica Scandinavica. 176(3). 293–300. 1 indexed citations
17.
Fröberg, Sven O. & Lars Orö. (1964). The Effect of Carotid Occlusion and Central Vagal Stimulation on the Free Fatty Acids of Plasma and the Blood Pressure in the Dog1. Acta Medica Scandinavica. 176(1). 65–71. 5 indexed citations
18.
Bergström, Sune, Lars A. Carlson, & Lars Orö. (1964). Effect of Prostaglandins on Gatecholamine Induced Changes in the Free Fatty Acids of Plasma and in Blood Pressure in the Dog Prostaglandin and related factors 22. Acta Physiologica Scandinavica. 60(1-2). 170–180. 99 indexed citations
19.
Fröberg, Sven O. & Lars Orö. (1963). The Effects of Nicotinic Acid, Phentolamine and Nethalide on the Plasma Free Fatty Acids and the Blood Pressure in the Dog A Comparative Study. Acta Medica Scandinavica. 174(5). 635–641. 23 indexed citations
20.
Carlson, Lars A. & Lars Orö. (1962). The Effect of Nicotinic Acid on the Plasma Free Fatty Acids Demonstration of a Metabolic Type of Sympathicolysis. Acta Medica Scandinavica. 172(6). 641–645. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harriet M. Maling Breakdown of academic impact, for papers by F. J. Haddy Breakdown of academic impact, for papers by J A Oates Breakdown of academic impact, for papers by J. Richard Crout Breakdown of academic impact, for papers by Samuel J. Friedberg Breakdown of academic impact, for papers by Andrew M. Michelakis Breakdown of academic impact, for papers by David L. Trout Breakdown of academic impact, for papers by Michael S. Golub Breakdown of academic impact, for papers by S Sgambato Breakdown of academic impact, for papers by McC. Goodall
Rankless by CCL
2026